The impact of tumor immunogenicity on cancer pain phenotype using syngeneic oral cancer mouse models.
Ontology highlight
ABSTRACT: Head and neck squamous cell carcinoma (HNSCC) patients report severe function-induced pain at the site of the primary tumor. The current hypothesis is that oral cancer pain is initiated and maintained in the cancer microenvironment due to secretion of algogenic mediators from tumor cells and surrounding immune cells that sensitize the primary sensory neurons innervating the tumor. Immunogenicity, which is the ability to induce an adaptive immune response, has been widely studied using cancer cell transplantation experiments. However, oral cancer pain studies have primarily used xenograft transplant models in which human-derived tumor cells are inoculated in an athymic mouse lacking an adaptive immune response; the role of inflammation in oral cancer-induced nociception is still unknown. Us
SUBMITTER: Horan NL
PROVIDER: S-EPMC9512086 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA